Department of Biochemistry, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-Ku, Nagoya, 466-8550, Japan.
Cell Tissue Res. 2018 May;372(2):211-221. doi: 10.1007/s00441-018-2796-z. Epub 2018 Feb 14.
Neuroblastoma is an embryonal malignancy that affects normal development of the adrenal medulla and paravertebral sympathetic ganglia in early childhood. Extensive studies have revealed the molecular characteristics of human neuroblastomas, including abnormalities at genome, epigenome and transcriptome levels. However, neuroblastoma initiation mechanisms and even its origin are long-standing mysteries. In this review article, we summarize the current knowledge about normal development of putative neuroblastoma sources, namely sympathoadrenal lineage of neural crest cells and Schwann cell precursors that were recently identified as the source of adrenal chromaffin cells. A plausible origin of enigmatic stage 4S neuroblastoma is also discussed. With regard to the initiation mechanisms, we review genetic abnormalities in neuroblastomas and their possible association to initiation mechanisms. We also summarize evidences of neuroblastoma initiation observed in genetically engineered animal models, in which epigenetic alterations were involved, including transcriptomic upregulation by N-Myc and downregulation by polycomb repressive complex 2. Finally, several in vitro experimental methods are proposed that hopefully will accelerate our comprehension of neuroblastoma initiation. Thus, this review summarizes the state-of-the-art knowledge about the mechanisms of neuroblastoma initiation, which is critical for developing new strategies to cure children with neuroblastoma.
神经母细胞瘤是一种胚胎性恶性肿瘤,影响婴幼儿时期肾上腺髓质和椎旁交感神经节的正常发育。大量研究揭示了人类神经母细胞瘤的分子特征,包括基因组、表观基因组和转录组水平的异常。然而,神经母细胞瘤的起始机制甚至其起源仍然是一个长期存在的谜团。在这篇综述文章中,我们总结了目前关于推定神经母细胞瘤来源(即最近被确定为肾上腺嗜铬细胞来源的神经嵴细胞和许旺细胞前体的交感肾上腺谱系)正常发育的知识。还讨论了神秘的 4S 期神经母细胞瘤的可能起源。关于起始机制,我们综述了神经母细胞瘤中的遗传异常及其与起始机制的可能关联。我们还总结了在遗传工程动物模型中观察到的神经母细胞瘤起始的证据,其中涉及表观遗传改变,包括 N-Myc 的转录组上调和多梳抑制复合物 2 的下调。最后,提出了几种体外实验方法,希望能加速我们对神经母细胞瘤起始的理解。因此,本综述总结了神经母细胞瘤起始机制的最新知识,这对于开发治疗神经母细胞瘤儿童的新策略至关重要。